These findings underscore the cooperative role of BRAFV600E and RNF43 mutations in driving a fully transformed, metastatic phenotype, with BRAFV600E serving as a potent enhancer of WNT signaling in colon cancer. This evidence concerns the gene RNF43 and malignant colon neoplasm.